Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Toxicol Environ Health. 1997 Aug 8;51(5):415-35.

Pathobiology of lipopolysaccharide.

Author information

  • 1Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock 72205, USA. pmayeux@biomed.uams.edu

Abstract

Lipopolysaccharide is a component of the gram-negative bacterial cell wall that is responsible for 25,000-50,000 deaths in the United States each year. The sequelae of gram-negative infection and septicemia leading to death include fever, hypotension with inadequate tissue perfusion, and disseminated intravascular coagulation. It is clear that different cell types respond differently to lipopolysaccharide. Furthermore, various autacoids and cytokines are released that can affect cellular function even in cell types that do not recognize lipopolysaccharide. Despite advances made in the etiology of septic shock and organ failure, therapy is still for the most part supportive and largely ineffective. The aim of this review is to summarize the current understanding of the role of lipopolysaccharide in the development of septicemia by examining signal transduction and therapeutic approaches.

PMID:
9233377
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk